HOME >> BIOLOGY >> NEWS
Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University

Snowmass, Co. (September 10, 2004) - Inflammatory Bowel Diseases, comprised of Crohn's Disease and ulcerative colitis, are for the most part incurable and their causes are still unknown. About 1 million Americans suffer from IBD and research around the world on new therapeutic strategies against IBD is being reported at a conference sponsored by the American Physiological Society.

On one thing most researchers agree on about IBD: it's very complex. And though it might seem obvious that treating a complex disease might take more than one agent, use of combination therapy hasn't been discussed much in relation to IBD.

Now separate groups working in Houston/Boston and Jerusalem have considered the implications of combination therapy in IBD. They are presenting their papers at the APS conference.

Intestinal Lactobacillus reuteri-based combination therapy directly modulates mucosal pro-inflammatory cytokine production in IL-10 deficient mice.

Probiotics and commensal bacteria represent likely sources for novel therapeutic strategies in inflammatory bowel diseases, and have become increasingly interesting to researchers. Indeed, some probiotic therapy agents are thought to be nearing the clinical trial stage. It is well-known that the human (and animal) gut is full of mostly beneficial bacteria. In IBD and other diseases researchers have taken an approach that reintroduces these positive bacteria, allow them to repopulate the gut and quite often they produce their own anti-inflammatory chemicals. One of the major such "bugs" is the genus Lactobacillus.

The research reported below was carried by James Versalovic and Jeremy Andrew Pena at the Baylor College of Medicine/Texas Children's Hospital, Houston, Texas, and by Arlin B. Rogers, Zhongming Ge and James G. Fox at the Division of Comparative Medicine at Massachusetts Institute of Technology, Cambridge, Mass.

Probiotics have demonstrated efficacy in treating patients
'"/>


10-Sep-2004


Page: 1 2 3

Related biology news :

1. Winning combination to build bone density in children
2. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
3. Researchers zero in on new drug combination strategy
4. IUB researchers to investigate genetic recombinations causes and consequences
5. Mutated protein combination tied to excessive sugar production
6. Clinical study reports findings of combination therapy with DOXIL
7. Novel COX-2 combination treatment may reduce colon cancer risk
8. Drug combination increases life span of mice with ALS
9. A combination of zinc and vitamin A may restore night vision in pregnant Nepalese women
10. Alcohol and thiamine deficiency together: a dangerous combination?
11. Inter-Element Recombination Between Retrotransposons May Be Strategy For Evolution Of Viruses Like HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/8/2019)... ... May 08, 2019 , ... MMS Holdings – an ... provided by Medrio , the leading provider of eClinical technology for small ... By collaborating to position high-quality CRO services with Medrio’s fast and easy-to-use eClinical ...
(Date:5/7/2019)... ... 07, 2019 , ... AMGtime will be exhibiting at the ... May 15- 17. At booth #226, AMGtime will be showcasing their comprehensive offerings ... mobile apps, specialized industry solutions, advanced add-on modules, seamless integrations, and more. Payroll ...
(Date:5/2/2019)... ... May 01, 2019 , ... uBiome, the leader in microbial ... Company’s General Counsel, as Interim Chief Executive Officer of uBiome, effective immediately. The ... leave. There will also be an independent investigation into uBiome’s billing practices to ...
Breaking Biology News(10 mins):
(Date:5/2/2019)... ... April 30, 2019 , ... The centuries old practice of brewing ... to local craft breweries, and even home brewing clubs scattered across the nation. ... processes, that when mastered can produce a superb product. Students at South Dakota ...
(Date:5/2/2019)... ... May 02, 2019 , ... Researchers from ... results documenting discrepancies between U.S. insurer policies for genetic testing and the 2019 ... hereditary breast and ovarian cancer (HBOC). , Jill S. Dolinsky, director ...
(Date:4/25/2019)... ... ... an albino, deaf Great Dane. His owners rescued him when he was four months old ... hearing impairment, he was always an active and playful pup. Frank bonded with his brother, ... the two grew, playtime became rougher and Frank ended up injuring his right rear leg. ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... research team that includes a chemical engineer at Worcester Polytechnic Institute (WPI) has ... may make it possible to manufacture isobutanol and other biofuels more economically. , ...
Breaking Biology Technology:
Cached News: